The DSM-5: A Vehicle for High-Profit Patent Extensions? Gregg Fields & Lisa Cosgrove
Listen now
Description
The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders affects drugs with sales in the billions of dollars. In research supported by the Edmond J. Safra Center for Ethics, Lisa Cosgrove of UMass-Boston investigated financial ties between DSM panel members and the pharmaceutical companies that have a vested interest in finding new indications for their blockbuster drugs. In this podcast, she tells journalist Gregg Fields what she found, what it means—and why we all should care.
"Tripartite Conflicts of Interest and High Stakes Patent Extensions in the DSM-5," Psychotherapy and Psychosomatics: www.karger.com/Article/FullText/357499.
More Episodes
Is blinding a possible solution to the implicit biases that exist throughout the healthcare and biomedical science fields? Christopher Robertson, a Lab affiliate and Associate Professor of Law at the University of Arizona, and former Lab Fellow Marie Newhouse examine the positives and negatives...
Published 12/05/14
After an introduction by Visiting Fellow Justin O’Brien on the limitations of current financial regulations both globally and domestically, journalist Gregg Fields interviews former Lab Fellow Kim Pernell-Gallagher on how divergent banking regulations in the years leading up to the recent...
Published 10/16/14
Many people are cynical about business promises and blame individual leaders when commitments are not kept. In this Labcast, Fellows Gregg Fields and Elizabeth Doty explore how systematic factors such as short-termism, complexity, reactivity, and operational issues also contribute to “commitment...
Published 07/22/14
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
